Biosensors and other
biological platform technologies require the
functionalization of their surface with receptors to enhance affinity
and selectivity. Control over the functionalization density is required
to tune the platform’s properties. Streptavidin (SAv) monolayers
are widely used to immobilize biotinylated proteins, receptors, and
DNA. The SAv density on a surface can be varied easily, but the predictability
is dependent on the method by which the SAv is immobilized. In this
study we show a method to quantitatively predict the SAv coverage
on biotinylated surfaces. The method is validated by measuring the
SAv coverage on supported lipid bilayers with a range of biotin contents
and two different main phase lipids and by using quartz crystal microbalance
and localized surface plasmon resonance. We explore a predictive model
of the biotin-dependent SAv coverage without any fit parameters. Model
and data allow to predict the SAv coverage based on the biotin coverage,
in both the low- and high-density regimes. This is of special importance
in applications with multivalent binding where control over surface
receptor density is required, but a direct measurement is not possible.